<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Senna: Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Senna: Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Senna: Drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_patient" data-topicid="12000" href="/d/html/12000.html" rel="external">see "Senna: Patient drug information"</a> and <a class="drug drug_pediatric" data-topicid="12786" href="/d/html/12786.html" rel="external">see "Senna: Pediatric drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F220473"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Ex-Lax Maximum Strength [OTC];</li>
<li>Ex-Lax [OTC];</li>
<li>FT Senna Laxatives [OTC];</li>
<li>Geri-kot [OTC];</li>
<li>GoodSense Laxative Pills [OTC];</li>
<li>GoodSense Senna Laxative [OTC];</li>
<li>OneLAX Senna [OTC];</li>
<li>Perdiem Overnight Relief [OTC];</li>
<li>Senna Laxative [OTC];</li>
<li>Senna Smooth [OTC];</li>
<li>Senna-GRX [OTC] [DSC];</li>
<li>Senna-Lax [OTC];</li>
<li>Senna-Tabs [OTC];</li>
<li>Senna-Time [OTC];</li>
<li>Sennazon [OTC];</li>
<li>Senno [OTC] [DSC];</li>
<li>Senokot Extra Strength [OTC];</li>
<li>Senokot Laxative Gummies [OTC];</li>
<li>Senokot [OTC]</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F220481"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Laxative, Stimulant</li></ul></div>
<div class="block doa drugH1Div" id="F220474"><span class="drugH1">Dosing: Adult</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Note: </b>Several types of senna products are available on the market and multiple formulations exist that are not equivalent; products composed of sennosides are considered OTC medications; senna pod concentrate and senna leaf extract are considered dietary supplements and are not interchangeable on a mL-to-mL (or mg-to-mg) basis with other senna products that contain sennosides; close attention must be paid to the product description and concentration when ordering or administering.</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="5cf5683d-351d-423d-a054-afa1e6798e5c">Constipation</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Constipation:</b> Oral:</p>
<p style="text-indent:-2em;margin-left:4em;">Sennosides:</p>
<p style="text-indent:-2em;margin-left:6em;">Syrup (8.8 mg sennosides/5 mL): 10 to 15 mL (17.6 mg to 26.4 mg sennosides) once daily; maximum: 15 mL (26.4 mg sennosides) twice daily.</p>
<p style="text-indent:-2em;margin-left:6em;">Tablets:</p>
<p style="text-indent:-2em;margin-left:8em;">8.6 mg sennosides/tablet: Two tablets (17.2 mg sennosides) once daily; maximum: 4 tablets (34.4 mg sennosides) twice daily</p>
<p style="text-indent:-2em;margin-left:8em;">15 mg sennosides/tablet: Two tablets (30 mg sennosides) once or twice daily</p>
<p style="text-indent:-2em;margin-left:8em;">17.2 mg sennosides/tablet: One tablet (17.2 mg sennosides) once daily; maximum: 2 tablets (34.4 mg sennosides) twice daily</p>
<p style="text-indent:-2em;margin-left:8em;">25 mg sennosides/tablet: Two tablets (50 mg sennosides) once or twice daily</p>
<p style="text-indent:-2em;margin-left:4em;">Senna leaf extract syrup (176 mg/5 mL senna leaf extract): <b>Note:</b> Senna leaf extract is considered a dietary supplement and is not interchangeable on a mL-to-mL (or mg-to-mg) basis with other senna products that contain sennosides.</p>
<p style="text-indent:-2em;margin-left:6em;">10 to 15 mL (352 to 528 mg senna leaf extract) once daily (preferably at bedtime); may increase to 10 to 15 mL (352 to 528 mg senna leaf extract) twice daily if needed; maximum daily dose: 30 mL/<b>day</b></p></div>
</div>
</div>
<div class="block doe drugH1Div" id="F220475"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block dop drugH1Div" id="F220478"><span class="drugH1">Dosing: Pediatric</span><p>(For additional information <a class="drug drug_pediatric" data-topicid="12786" href="/d/html/12786.html" rel="external">see "Senna: Pediatric drug information"</a>)</p>
<p style="text-indent:0em;display:inline">
<b>Note:</b> Several types of senna products are available on the market and multiple formulations exist that are not equivalent; pay close attention to the product description and concentration when ordering, dispensing, or administering. Products composed of sennosides are considered OTC medications; senna pod concentrate and senna leaf extract are considered dietary supplements and are not interchangeable on a mL to mL (or mg to mg) basis with other senna products that contain sennosides. Approved ages for generic products may vary; consult labeling for specific information.</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="5cf5683d-351d-423d-a054-afa1e6798e5c">Constipation</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Constipation:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note: </b>Other agents (eg, polyethylene glycol 3350) are preferred for constipation maintenance therapy. Stimulant laxatives (eg, senna) may be used as additional or second-line therapy for short-term use (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-24345831']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-24345831'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Sennosides:</p>
<p style="text-indent:-2em;margin-left:6em;">Syrup (8.8 mg sennosides/5 mL):</p>
<p style="text-indent:-2em;margin-left:8em;">Children &lt;2 years: Very limited data available: Oral: 1.25 to 2.5 mL (2.2 to 4.4 mg sennosides) per day; maximum daily dose: 5 mL (8.8 mg sennosides) per <b>day</b> (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-20971414']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-20971414'])">Ref</a></span>). <b>Note</b>
<b>:</b> Use with caution in young children (particularly those not toilet trained); senna may cause perianal skin breakdown and blistering if the stool is left in contact with the skin for a prolonged time and/or if high doses are administered (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28111797','lexi-content-ref-29429768']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28111797','lexi-content-ref-29429768'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:8em;">Children 2 to &lt;6 years: Oral: 2.5 to 3.75 mL (4.4 to 6.6 mg sennosides) at bedtime; maximum daily dose: 3.75 mL (6.6 mg sennosides) twice daily. <b>Note:</b> Use with caution in young children (particularly those not toilet trained); senna may cause perianal skin breakdown and blistering if the stool is left in contact with the skin for a prolonged time and/or if high doses are administered (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28111797','lexi-content-ref-29429768']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28111797','lexi-content-ref-29429768'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:8em;">Children 6 to &lt;12 years: Oral: 5 to 7.5 mL (8.8 to 13.2 mg sennosides) at bedtime; maximum daily dose: 7.5 mL (13.2 mg sennosides) twice daily.</p>
<p style="text-indent:-2em;margin-left:8em;">Children ≥12 years and Adolescents: Oral: 10 to 15 mL (17.6 to 26.4 mg sennosides) at bedtime; maximum daily dose: 15 mL (26.4 mg sennosides) twice daily.</p>
<p style="text-indent:-2em;margin-left:6em;">Tablets:</p>
<p style="text-indent:-2em;margin-left:8em;">
<i>3 mg sennosides per chewable tablet (eg, Genexa Kids Senna Laxative):</i></p>
<p style="text-indent:-2em;margin-left:10em;">Children 2 to &lt;6 years: Oral: 1 tablet (3 mg sennosides) once or twice daily. <b>Note:</b> Use with caution in young children (particularly those not toilet trained); senna may cause perianal skin breakdown and blistering if the stool is left in contact with the skin for a prolonged time and/or if high doses are administered (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28111797','lexi-content-ref-29429768']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28111797','lexi-content-ref-29429768'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:10em;">Children 6 to &lt;12 years: Oral: 2 tablets (6 mg sennosides) once or twice daily.</p>
<p style="text-indent:-2em;margin-left:8em;">
<i>8.6 mg sennosides per tablet (eg, Senokot):</i></p>
<p style="text-indent:-2em;margin-left:10em;">Children 2 to &lt;6 years: Oral: <sup>1</sup>/<sub>2</sub> tablet (4.3 mg sennosides) at bedtime; maximum daily dose: 1 tablet (8.6 mg sennosides) twice daily. <b>Note:</b> Use with caution in young children (particularly those not toilet trained); senna may cause perianal skin breakdown and blistering if the stool is left in contact with the skin for a prolonged time and/or if high doses are administered (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28111797','lexi-content-ref-29429768']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28111797','lexi-content-ref-29429768'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:10em;">Children 6 to &lt;12 years: Oral: 1 tablet (8.6 mg sennosides) at bedtime; maximum daily dose: 2 tablets (17.2 mg sennosides) twice daily.</p>
<p style="text-indent:-2em;margin-left:10em;">Children ≥12 years and Adolescents: Oral: 2 tablets (17.2 mg sennosides) at bedtime; maximum daily dose: 4 tablets (34.4 mg sennosides) twice daily.</p>
<p style="text-indent:-2em;margin-left:8em;">
<i>12 mg sennosides per tablet (eg, Genexa Senna Laxative):</i></p>
<p style="text-indent:-2em;margin-left:10em;">Children 6 to &lt;12 years: Oral: <sup>1</sup>/<sub>2</sub> tablet (6 mg sennosides) once or twice daily.</p>
<p style="text-indent:-2em;margin-left:10em;">Children ≥12 years and Adolescents: Oral: 1 tablet (12 mg sennosides) once or twice daily.</p>
<p style="text-indent:-2em;margin-left:8em;">
<i>15 mg sennosides per tablet (eg, Ex-Lax Regular Strength):</i></p>
<p style="text-indent:-2em;margin-left:10em;">Children 6 to &lt;12 years: Oral: 1 tablet (15 mg sennosides) once or twice daily.</p>
<p style="text-indent:-2em;margin-left:10em;">Children ≥12 years and Adolescents: Oral: 2 tablets (30 mg sennosides) once or twice daily.</p>
<p style="text-indent:-2em;margin-left:8em;">
<i>17.2 mg sennosides per tablet (eg, SenokotXTRA):</i></p>
<p style="text-indent:-2em;margin-left:10em;">Children 6 to &lt;12 years: Oral: <sup>1</sup>/<sub>2</sub> tablet (8.6 mg sennosides) at bedtime; maximum daily dose: 1 tablet (17.2 mg sennosides) twice daily.</p>
<p style="text-indent:-2em;margin-left:10em;">Children ≥12 years and Adolescents: Oral: 1 tablet (17.2 mg sennosides) at bedtime; maximum daily dose: 2 tablets (34.4 mg sennosides) twice daily.</p>
<p style="text-indent:-2em;margin-left:8em;">
<i>25 mg sennosides per tablet (eg, Ex-Lax Maximum Strength):</i></p>
<p style="text-indent:-2em;margin-left:10em;">Children 6 to &lt;12 years: Oral: 1 tablet (25 mg sennosides) once or twice daily.</p>
<p style="text-indent:-2em;margin-left:10em;">Children ≥12 years and Adolescents: Oral: 2 tablets (50 mg sennosides) once or twice daily.</p>
<p style="text-indent:-2em;margin-left:4em;">Senna pod concentrate liquid (Fletcher's Laxative for Kids; 167 mg/5 mL senna pod concentrate): <b>Note:</b> Senna pod concentrate is considered a dietary supplement and is not interchangeable on a mL to mL (or mg to mg) basis with other senna products.</p>
<p style="text-indent:-2em;margin-left:6em;">Children 2 to &lt;6 years: Oral: 5 to 10 mL (167 to 334 mg senna pod concentrate) once or twice daily. <b>Note:</b> Use with caution in younger children (particularly those not toilet trained); senna may cause perianal skin breakdown and blistering if the stool is left in contact with the skin for a prolonged time and/or if high doses are administered (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28111797','lexi-content-ref-29429768']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28111797','lexi-content-ref-29429768'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">Children ≥6 years and Adolescents ≤15 years: Oral: 10 to 15 mL (334 to 501 mg senna pod concentrate) once or twice daily.</p>
<p style="text-indent:-2em;margin-left:4em;">Senna Leaf Extract Syrup (176 mg/5 mL senna leaf extract): <b>Note:</b> Senna leaf extract is considered a dietary supplement and is not interchangeable on a mL to mL (or mg to mg) basis with other senna products.</p>
<p style="text-indent:-2em;margin-left:6em;">Children 2 to &lt;6 years: Oral: 2.5 to 3.75 mL (88 to 132 mg senna leaf extract) once daily; maximum daily dose: 3.75 mL (132 mg senna leaf extract) twice daily. <b>Note:</b> Use with caution in younger children (particularly those not toilet trained); senna may cause perianal skin breakdown and blistering if the stool is left in contact with the skin for a prolonged time and/or if high doses are administered (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28111797','lexi-content-ref-29429768']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28111797','lexi-content-ref-29429768'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">Children ≥6 years to &lt;12 years: Oral: 5 to 7.5 mL (176 to 264 mg senna leaf extract) once daily; maximum daily dose: 7.5 mL (264 mg senna leaf extract) twice daily.</p>
<p style="text-indent:-2em;margin-left:6em;">Children ≥12 years and Adolescents: Oral: 10 to 15 mL (352 to 528 mg senna leaf extract) once daily; maximum daily dose: 15 mL (528 mg senna leaf extract) twice daily.</p></div>
</div>
</div>
<div class="block adr drugH1Div" id="F220460"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:-2em;margin-left:2em;">Frequency not defined: Gastrointestinal: Abdominal cramps, diarrhea, nausea, vomiting</p></div>
<div class="block war drugH1Div" id="F220457"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Dosage form specific issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Benzyl alcohol and derivatives: Some dosage forms may contain sodium benzoate/benzoic acid; benzoic acid (benzoate) is a metabolite of benzyl alcohol; large amounts of benzyl alcohol (≥99 mg/kg/day) have been associated with a potentially fatal toxicity (“gasping syndrome”) in neonates; the “gasping syndrome” consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension, and cardiovascular collapse (AAP ["Inactive" 1997]; CDC 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors 2001); avoid or use dosage forms containing benzyl alcohol derivative with caution in neonates. See manufacturer’s labeling.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Appropriate use: Failure to have a bowel movement or occurrence of rectal bleeding after use should be reported to health care provider.</p>
<p style="text-indent:-2em;margin-left:4em;">• Self-medication (OTC use): Not recommended for use in patients experiencing stomach pain, nausea, vomiting, or a sudden change in bowel movements which lasts &gt;2 weeks. Not recommended for OTC use in children &lt;2 years of age. Do not use for more than 1 week.</p></div>
<div class="block add-pediatric-warn-info drugH1Div" id="F56990423"><span class="drugH1">Warnings: Additional Pediatric Considerations</span>
<p style="text-indent:0em;display:inline">Use with caution in younger children (particularly those not toilet trained); senna may cause perianal skin breakdown and blistering if the stool is left in contact with the skin for a prolonged time and/or if high doses are administered (Cogley 2017; Vilanova-Sanchez 2018).</p></div>
<div class="block foc drugH1Div" id="F220464"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Leaves, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic:  (454 g [DSC])</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Liquid, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 8.8 mg/5 mL (237 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Syrup, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">OneLAX Senna: 8.8 mg/5 mL (237 mL) [alcohol free, gluten free, paraben free, sugar free; contains saccharin sodium, sodium benzoate]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Senna-GRX: 8.8 mg/5 mL (15 mL [DSC], 236 mL [DSC]) [contains parabens, propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Sennazon: 8.8 mg/5 mL (237 mL) [alcohol free; contains methylparaben, propylene glycol, propylparaben; chocolate flavor]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 8.8 mg/5 mL (5 mL, 15 mL, 236 mL [DSC], 237 mL); 176 mg/5 mL (15 mL, 237 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Tablet, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Ex-Lax Maximum Strength: 25 mg [contains corn starch, fd&amp;c blue #1 (brill blue) aluminum lake, methylparaben, propylparaben, sodium benzoate]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">FT Senna Laxatives: 8.6 mg</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Geri-kot: 8.6 mg</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">GoodSense Laxative Pills: 25 mg [contains corn starch, fd&amp;c blue #1 (brilliant blue)]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">GoodSense Senna Laxative: 8.6 mg</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Perdiem Overnight Relief: 15 mg [contains corn starch, methylparaben, propylparaben, sodium benzoate]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Senna Laxative: 8.6 mg</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Senna Smooth: 15 mg [contains sodium benzoate]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Senna-Lax: 8.6 mg</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Senna-Tabs: 8.6 mg</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Senna-Time: 8.6 mg</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Senno: 8.6 mg [DSC]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Senokot: 8.6 mg</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Senokot Extra Strength: 17.2 mg</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 8.6 mg</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Tablet Chewable, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Ex-Lax: 15 mg [contains soybean lecithin, whey; chocolate flavor]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Senokot Laxative Gummies: 8.7 mg [contains coconut oil (copra/cocos nucifera oil)]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Senokot Laxative Gummies: 8.7 mg [dairy free, egg free, fish derivative free, gluten free, peanut free, shellfish free, soy free; contains coconut oil (copra/cocos nucifera oil)]</p></div>
<div class="block geq drugH1Div" id="F220454"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">May be product dependent</p></div>
<div class="block fee drugH1Div" id="F6487656"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Chewable</b> (Ex-Lax Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">15 mg (per each): $0.18</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Chewable</b> (Senokot Laxative Gummies Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">8.7 mg (per each): $0.24</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Syrup</b> (OneLAX Senna Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">8.8 mg/5 mL (per mL): $0.04</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Syrup</b> (Senna Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">176 mg/5 mL (per mL): $0.05 - $0.07</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Tablets</b> (Ex-Lax Maximum Strength Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">25 mg (per each): $0.23</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Tablets</b> (Perdiem Overnight Relief Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">15 mg (per each): $0.15</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Tablets</b> (Senna Smooth Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">15 mg (per each): $0.22</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Tablets</b> (Senokot Extra Strength Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">17.2 mg (per each): $0.50</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Tablets</b> (Senokot Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">8.6 mg (per each): $0.24</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block adm drugH1Div" id="F220467"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">Once-daily doses should be preferentially taken at bedtime. Administer 2 hours before or after other medications.</p></div>
<div class="block admp drugH1Div" id="F52613846"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Oral: Administer at bedtime (preferable) with water; syrup can be taken with juice or milk or mixed with ice cream to mask taste. Administer 2 hours before or after other medications.</p></div>
<div class="block use drugH1Div" id="F220465"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:0em;display:inline">
<b>Constipation:</b> Relieves occasional constipation (irregularity); generally causes bowel movement in 6 to 12 hours</p></div>
<div class="block off-label drugH1Div" id="F28008798"><span class="drugH1">Use: Off-Label: Adult</span><p>Colonic cleansing before colonoscopy (adjunct)</p></div>
<div class="block mst drugH1Div" id="F220487"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Sound-alike/look-alike issues: </span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Perdiem may be confused with Pyridium</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Senexon may be confused with Cenestin</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Senokot may be confused with Depakote</p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F13300035"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F6222897"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">Dichlorphenamide: Laxatives may enhance the hypokalemic effect of Dichlorphenamide. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Digoxin: Senna may enhance the adverse/toxic effect of Digoxin. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Polyethylene Glycol-Electrolyte Solution: Laxatives (Stimulant) may enhance the adverse/toxic effect of Polyethylene Glycol-Electrolyte Solution. Specifically, the risk of colonic mucosal aphthous ulcerations may be increased.  Management: Consider avoiding this combination due to a potential for increased risk of colonic mucosal aphthous ulcerations.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Sodium Sulfate: Laxatives (Stimulant) may enhance the adverse/toxic effect of Sodium Sulfate. Specifically, the risk of mucosal ulceration or ischemic colitis may be increased. <i> Risk X: Avoid combination</i></p></div>
<div class="block pri drugH1Div" id="F14079765"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;">Use of senna should be limited during pregnancy due to an increased risk of adverse events, such as electrolyte abnormalities. When dietary changes and lifestyle modifications are insufficient, agents other than senna are recommended for the treatment of constipation in pregnant women (Body 2016; Gomes 2018).</p></div>
<div class="block brc drugH1Div" id="F14079766"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:-2em;margin-left:2em;">Rhein, an active metabolite of senna, is present in breast milk.</p>
<p style="text-indent:-2em;margin-left:2em;margin-top:0em;">Breast milk was sampled following maternal administration of sennosides A+B (equivalent to ~sennosides 15 mg [rhein 9.8 mg]) and plantago to 20 women. Dosing occurred in the evening of postpartum days 2, 3, and 4. Breast milk was sampled prior to and for 26 hours after the last dose. The highest concentrations of rhein were found 10 hours after the dose, which was the first sample following drug administration. Rhein was still measurable in breast milk 26 hours after the dose in half of the women. Authors of the study calculated the daily amount of rhein present in breast milk to be 0.007% of the maternal dose (Faber 1988).</p>
<p style="text-indent:-2em;margin-left:2em;margin-top:0em;">Although there have been reports of diarrhea or loose stools in breastfeeding infants, bowel patterns were not changed in most cases (Baldwin 1963; Duncan 1957; Greenhalf 1973; Shelton 1980; Werthmann 1973). The WHO considers use of senna for maternal constipation to be compatible with breastfeeding; however, it should only be used when dietary changes are inadequate (WHO 2002).</p></div>
<div class="block pha drugH1Div" id="F47059477"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;margin-left:0em;display:inline">The anthraquinone group of stimulant laxatives includes the plant-derived agents such as senna. Stimulant laxatives typically induce defecation by stimulating peristaltic activity on the intestine by direct action on intestinal mucosa or nerve plexus, therefore increasing motility.</p></div>
<div class="block phk drugH1Div" id="F46149049"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;">Onset of action: Oral: Within 6 to 24 hours</p>
<p style="text-indent:-2em;margin-left:2em;">Metabolism: Hepatic</p>
<p style="text-indent:-2em;margin-left:2em;">Excretion: Feces (via bile); urine </p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F5539927"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(AE)</span> <span class="country">United Arab Emirates</span><span class="countrySeparator">: </span><span class="drugName">Pursennid | Senokot</span>;</li>
<li>
<span class="countryCode">(AT)</span> <span class="country">Austria</span><span class="countrySeparator">: </span><span class="drugName">Colonorm | Darmol | Dragee 19 senna | Pursennid | X prep</span>;</li>
<li>
<span class="countryCode">(AU)</span> <span class="country">Australia</span><span class="countrySeparator">: </span><span class="drugName">Laxette c senna | Laxettes | Laxettes senna laxative | Sennaplus | Senokot</span>;</li>
<li>
<span class="countryCode">(BD)</span> <span class="country">Bangladesh</span><span class="countrySeparator">: </span><span class="drugName">Laxenna</span>;</li>
<li>
<span class="countryCode">(BE)</span> <span class="country">Belgium</span><span class="countrySeparator">: </span><span class="drugName">Senokot</span>;</li>
<li>
<span class="countryCode">(BG)</span> <span class="country">Bulgaria</span><span class="countrySeparator">: </span><span class="drugName">Senna | X prep</span>;</li>
<li>
<span class="countryCode">(CH)</span> <span class="country">Switzerland</span><span class="countrySeparator">: </span><span class="drugName">Pursennid | Senokot</span>;</li>
<li>
<span class="countryCode">(CO)</span> <span class="country">Colombia</span><span class="countrySeparator">: </span><span class="drugName">Ex-lax | Laxacol | Laxalud | Sennax</span>;</li>
<li>
<span class="countryCode">(CZ)</span> <span class="country">Czech Republic</span><span class="countrySeparator">: </span><span class="drugName">Tisasen</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Depuran | Palamkotta | X prep</span>;</li>
<li>
<span class="countryCode">(DO)</span> <span class="country">Dominican Republic</span><span class="countrySeparator">: </span><span class="drugName">Pursennid | Senokot</span>;</li>
<li>
<span class="countryCode">(EC)</span> <span class="country">Ecuador</span><span class="countrySeparator">: </span><span class="drugName">Ex-lax | Senokot</span>;</li>
<li>
<span class="countryCode">(EE)</span> <span class="country">Estonia</span><span class="countrySeparator">: </span><span class="drugName">Senadexin | X prep</span>;</li>
<li>
<span class="countryCode">(EG)</span> <span class="country">Egypt</span><span class="countrySeparator">: </span><span class="drugName">Diolax | Purgaton | Senna lax</span>;</li>
<li>
<span class="countryCode">(ES)</span> <span class="country">Spain</span><span class="countrySeparator">: </span><span class="drugName">Puntualex | Pursenid</span>;</li>
<li>
<span class="countryCode">(FI)</span> <span class="country">Finland</span><span class="countrySeparator">: </span><span class="drugName">Exprep | Pursennid Ex-lax | Sennapur | Senokot</span>;</li>
<li>
<span class="countryCode">(FR)</span> <span class="country">France</span><span class="countrySeparator">: </span><span class="drugName">Herbesan | Pursennide | Senokot</span>;</li>
<li>
<span class="countryCode">(GB)</span> <span class="country">United Kingdom</span><span class="countrySeparator">: </span><span class="drugName">Bidrolar | Ex lax senna | Senease | Senlax | Senna | Senokot | X prep</span>;</li>
<li>
<span class="countryCode">(GR)</span> <span class="country">Greece</span><span class="countrySeparator">: </span><span class="drugName">Exlax | Pursenide | X prep</span>;</li>
<li>
<span class="countryCode">(HK)</span> <span class="country">Hong Kong</span><span class="countrySeparator">: </span><span class="drugName">Neolax | Pms Sennosides | Regultabs | Senna | Sennoside | Senokot | Senoside | Syntolax</span>;</li>
<li>
<span class="countryCode">(HU)</span> <span class="country">Hungary</span><span class="countrySeparator">: </span><span class="drugName">Darmol | Tisasen | Tisasen a+b | X prep | X prep 75</span>;</li>
<li>
<span class="countryCode">(IE)</span> <span class="country">Ireland</span><span class="countrySeparator">: </span><span class="drugName">Senokot</span>;</li>
<li>
<span class="countryCode">(IL)</span> <span class="country">Israel</span><span class="countrySeparator">: </span><span class="drugName">Pursennid | X prep</span>;</li>
<li>
<span class="countryCode">(IN)</span> <span class="country">India</span><span class="countrySeparator">: </span><span class="drugName">Laxton</span>;</li>
<li>
<span class="countryCode">(IR)</span> <span class="country">Iran, Islamic Republic of</span><span class="countrySeparator">: </span><span class="drugName">Senagole</span>;</li>
<li>
<span class="countryCode">(IT)</span> <span class="country">Italy</span><span class="countrySeparator">: </span><span class="drugName">Falquilax | Pursennid | X prep</span>;</li>
<li>
<span class="countryCode">(JO)</span> <span class="country">Jordan</span><span class="countrySeparator">: </span><span class="drugName">Senokot</span>;</li>
<li>
<span class="countryCode">(JP)</span> <span class="country">Japan</span><span class="countrySeparator">: </span><span class="drugName">Cathartin | Forsenid | Laxsorone | Penclusin | Purnoside | Pursennid | Ritasend sanken | Ritasend tsuruhara | Satolax choco | Senan | Senevacul kaigen | Senevacul merck hoei | Senevacul seiko | Senevacul towa | Sennal | Sennal nichiiko | Sennal yoshindo | Sennaride hexal | Sennaride sanken | Sennasid | Senno a.b | Sennoside | Sennoside beppu | Sennoside Fuso | Sennoside jd | Sennoside kunihiro | Sennoside matsuura | Sennoside mita | Sennoside miyarisa | Sennoside pfizer | Sennoside sawai | Sennoside seiko | Sennoside taisho | Sennoside taiyo | Sennoside takeda teva | Sennoside towa | Sennoside yamakawa | Senokot | Soldol e | Tinelac</span>;</li>
<li>
<span class="countryCode">(KE)</span> <span class="country">Kenya</span><span class="countrySeparator">: </span><span class="drugName">Laxton | Senokot</span>;</li>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">Dulax | Spilax</span>;</li>
<li>
<span class="countryCode">(KW)</span> <span class="country">Kuwait</span><span class="countrySeparator">: </span><span class="drugName">Laxal | Purgaton | Senokot</span>;</li>
<li>
<span class="countryCode">(LB)</span> <span class="country">Lebanon</span><span class="countrySeparator">: </span><span class="drugName">Pursennid</span>;</li>
<li>
<span class="countryCode">(LT)</span> <span class="country">Lithuania</span><span class="countrySeparator">: </span><span class="drugName">Glaxena | Tisasen | X prep</span>;</li>
<li>
<span class="countryCode">(LU)</span> <span class="country">Luxembourg</span><span class="countrySeparator">: </span><span class="drugName">Senokot</span>;</li>
<li>
<span class="countryCode">(LV)</span> <span class="country">Latvia</span><span class="countrySeparator">: </span><span class="drugName">Alax | Glaxena | Senadexin | Sennozid | Tisasen | X prep</span>;</li>
<li>
<span class="countryCode">(MA)</span> <span class="country">Morocco</span><span class="countrySeparator">: </span><span class="drugName">Pursennide</span>;</li>
<li>
<span class="countryCode">(MX)</span> <span class="country">Mexico</span><span class="countrySeparator">: </span><span class="drugName">C motil | Caspharma | Chocolax | Fiesole | Isilax | Lagenbach | Novakosid | Sekelax | Senokot | Senokot f | Senosidos AB | Sinbiotrex | X prep</span>;</li>
<li>
<span class="countryCode">(MY)</span> <span class="country">Malaysia</span><span class="countrySeparator">: </span><span class="drugName">Senna | Senokot</span>;</li>
<li>
<span class="countryCode">(NL)</span> <span class="country">Netherlands</span><span class="countrySeparator">: </span><span class="drugName">X-Praep</span>;</li>
<li>
<span class="countryCode">(NO)</span> <span class="country">Norway</span><span class="countrySeparator">: </span><span class="drugName">Pursennid | Senokot</span>;</li>
<li>
<span class="countryCode">(NZ)</span> <span class="country">New Zealand</span><span class="countrySeparator">: </span><span class="drugName">Senokot</span>;</li>
<li>
<span class="countryCode">(PE)</span> <span class="country">Peru</span><span class="countrySeparator">: </span><span class="drugName">Ex-lax | Senokot</span>;</li>
<li>
<span class="countryCode">(PH)</span> <span class="country">Philippines</span><span class="countrySeparator">: </span><span class="drugName">Senalax | Senokot | Senokot forte</span>;</li>
<li>
<span class="countryCode">(PK)</span> <span class="country">Pakistan</span><span class="countrySeparator">: </span><span class="drugName">Clearlax | Senokot</span>;</li>
<li>
<span class="countryCode">(PL)</span> <span class="country">Poland</span><span class="countrySeparator">: </span><span class="drugName">Senalax extra</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Gentlax | Perdiem overnight relief | Senna | Senna time | Senokot | Senokot xtra</span>;</li>
<li>
<span class="countryCode">(PT)</span> <span class="country">Portugal</span><span class="countrySeparator">: </span><span class="drugName">Pursenide | Pursennide | X prep</span>;</li>
<li>
<span class="countryCode">(QA)</span> <span class="country">Qatar</span><span class="countrySeparator">: </span><span class="drugName">Laxal | Laxasenna | Senokot</span>;</li>
<li>
<span class="countryCode">(RU)</span> <span class="country">Russian Federation</span><span class="countrySeparator">: </span><span class="drugName">Ex-lax | Glaxena | Pursennid | Senadexin | Senalex | Sennalax | Sennaplant | Tisasen | Tisasen ab | X prep</span>;</li>
<li>
<span class="countryCode">(SA)</span> <span class="country">Saudi Arabia</span><span class="countrySeparator">: </span><span class="drugName">Lax a senna | Laxal | Purgaton | Pursennid | Senna lax | Senokot</span>;</li>
<li>
<span class="countryCode">(SE)</span> <span class="country">Sweden</span><span class="countrySeparator">: </span><span class="drugName">Pursennid ex-lax</span>;</li>
<li>
<span class="countryCode">(SG)</span> <span class="country">Singapore</span><span class="countrySeparator">: </span><span class="drugName">Senna | Senokot</span>;</li>
<li>
<span class="countryCode">(SI)</span> <span class="country">Slovenia</span><span class="countrySeparator">: </span><span class="drugName">Coloclens | X prep</span>;</li>
<li>
<span class="countryCode">(SK)</span> <span class="country">Slovakia</span><span class="countrySeparator">: </span><span class="drugName">Tisasen | X prep</span>;</li>
<li>
<span class="countryCode">(TH)</span> <span class="country">Thailand</span><span class="countrySeparator">: </span><span class="drugName">Pursennid | Senokot</span>;</li>
<li>
<span class="countryCode">(TN)</span> <span class="country">Tunisia</span><span class="countrySeparator">: </span><span class="drugName">Pursennide | Senokot</span>;</li>
<li>
<span class="countryCode">(TR)</span> <span class="country">Turkey</span><span class="countrySeparator">: </span><span class="drugName">Laxeno | Laxeno diet | Pursennid | Roha lax | Senokot | X m diet | X-M</span>;</li>
<li>
<span class="countryCode">(TW)</span> <span class="country">Taiwan</span><span class="countrySeparator">: </span><span class="drugName">Baechance | Laxaside | Loxer | Pursennid | Sena D.C. | Senlax | Sennapur | Sennasid | Sennoside | Senokot | Through | X prep</span>;</li>
<li>
<span class="countryCode">(UA)</span> <span class="country">Ukraine</span><span class="countrySeparator">: </span><span class="drugName">Senade | Senadexin | Senadin | Senalde</span>;</li>
<li>
<span class="countryCode">(VE)</span> <span class="country">Venezuela, Bolivarian Republic of</span><span class="countrySeparator">: </span><span class="drugName">Ex-lax | Prex | Sen | Senlax | Senokot</span>;</li>
<li>
<span class="countryCode">(ZA)</span> <span class="country">South Africa</span><span class="countrySeparator">: </span><span class="drugName">Adco-senna | Gal Tablette NF | Laxador senna | Lennon senna | Senna Pin | Senokot | Soflax | Tummy lax | X prep</span>;</li>
<li>
<span class="countryCode">(ZM)</span> <span class="country">Zambia</span><span class="countrySeparator">: </span><span class="drugName">Adco-senna | Senokot</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-19491001">
<a name="19491001"></a>Acs N, Bánhidy F, Puhó EH, Czeizel AE. Senna treatment in pregnant women and congenital abnormalities in their offspring--a population-based case-control study. <i>Reprod Toxicol</i>. 2009;28:100-104.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/senna-drug-information/abstract-text/19491001/pubmed" id="19491001" target="_blank">19491001</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11487763">
<a name="11487763"></a>Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. <i>J Pediatr</i>. 2001;139(2):317-319.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/senna-drug-information/abstract-text/11487763/pubmed" id="11487763" target="_blank">11487763</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27060684">
<a name="27060684"></a>Anderson PO, Sauberan JB. Modeling drug passage into human milk. <i>Clin Pharmacol Ther</i>. 2016;100(1):42-52.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/senna-drug-information/abstract-text/27060684/pubmed" id="27060684" target="_blank">27060684</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-14045350">
<a name="14045350"></a>Baldwin WF. Clinical study of senna administration to nursing mothers: assessment of effects on infant bowel habits. <i>Can Med Assoc J</i>. 1963;89:566-568.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/senna-drug-information/abstract-text/14045350/pubmed" id="14045350" target="_blank">14045350</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20971414">
<a name="20971414"></a>Blackmer AB, Farrington EA. Constipation in the pediatric patient: an overview and pharmacologic considerations. <i>J Pediatr Health Care</i>. 2010;24(6):385-99. doi:10.1016/j.pedhc.2010.09.003<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/senna-drug-information/abstract-text/20971414/pubmed" id="20971414" target="_blank">20971414</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27261898">
<a name="27261898"></a>Body C, Christie JA. Gastrointestinal diseases in pregnancy: nausea, vomiting, hyperemesis gravidarum, gastroesophageal reflux disease, constipation, and diarrhea. <i>Gastroenterol Clin North Am</i>. 2016;45(2):267‐283. doi:10.1016/j.gtc.2016.02.005<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/senna-drug-information/abstract-text/27261898/pubmed" id="27261898" target="_blank">27261898</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-6810084">
<a name="6810084"></a>Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol—United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982;31(22):290-291. <a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm" target="_blank">http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm</a>
<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/senna-drug-information/abstract-text/6810084/pubmed" id="6810084" target="_blank">6810084</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28111797">
<a name="28111797"></a>Cogley K, Echevarria A, Correa C, De la Torre-Mondragón L. Contact burn with blister formation in children treated with sennosides. <i>Pediatr Dermatol</i>. 2017;34(2):e85-e88. doi:10.1111/pde.13068<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/senna-drug-information/abstract-text/28111797/pubmed" id="28111797" target="_blank">28111797</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-13396280">
<a name="13396280"></a>Duncan AS. Standardized senna as a laxative in the puerperium; a clinical assessment. <i>Br Med J</i>. 1957;1(5016):439-441.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/senna-drug-information/abstract-text/13396280/pubmed" id="13396280" target="_blank">13396280</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Ex-Lax Maximum Strength tablets (sennosides) [prescribing information]. Parsippany, NJ: Novartis; February 2013.</div>
</li>
<li>
<div class="reference">
                  Ex-Lax Maximum Strength tablets (sennosides) [prescribing information]. Parsippany, NJ: Novartis; received May 2022.</div>
</li>
<li>
<div class="reference">
                  Ex-Lax Regular Strength chewable tablet (senna) [prescribing information]. Parsippany; NJ: Novartis Consumer Health, Inc; September 2014.</div>
</li>
<li>
<div class="reference">
                  Ex-Lax Regular Strength tablets (sennosides) [prescribing information]. Parsippany, NJ: Novartis; received May 2022.</div>
</li>
<li>
<div class="reference">
                  Fletcher's Laxative (senna) [prescribing information]. Orchard Park, NY: The Mentholatum Company; received 2018.</div>
</li>
<li>
<div class="reference">
                  Genexa Kids (senna) [prescribing information]. Atlanta, GA: Genexa Inc; August 2021.</div>
</li>
<li>
<div class="reference">
                  Genexa Laxative (senna) [prescribing information]. Los Angeles, GA: Genexa Inc; October 2020.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9024461">
<a name="9024461"></a>"Inactive" ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics (AAP) Committee on Drugs. <i>Pediatrics</i>. 1997;99(2):268-278.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/senna-drug-information/abstract-text/9024461/pubmed" id="9024461" target="_blank">9024461</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29991883">
<a name="29991883"></a>Gomes CF, Sousa M, Lourenço I, Martins D, Torres J. Gastrointestinal diseases during pregnancy: what does the gastroenterologist need to know? <i>Ann Gastroenterol</i>. 2018;31(4):385‐394. doi:10.20524/aog.2018.0264<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/senna-drug-information/abstract-text/29991883/pubmed" id="29991883" target="_blank">29991883</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-4570522">
<a name="4570522"></a>Greenhalf JO, Leonard HS. Laxatives in the treatment of constipation in pregnant and breast-feeding mothers. <i>Practitioner</i>. 1973;210(256):259-263.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/senna-drug-information/abstract-text/4570522/pubmed" id="4570522" target="_blank">4570522</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16482236">
<a name="16482236"></a>Hookey LC, Depew WT, Vanner SJ. Combined low-volume polyethylene glycol solution plus stimulant laxatives versus standard-volume polyethylene glycol solution: A prospective, randomized study of colon cleansing before colonoscopy. <i>Can J Gastroenterol</i>, 2006;20(2):101-105.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/senna-drug-information/abstract-text/16482236/pubmed" id="16482236" target="_blank">16482236</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-1468604">
<a name="1468604"></a>Iida Y, Miura S, Asada Y, et al. Bowel preparation for the total colonoscopy by 2,000 mL of balanced lavage solution (Golytely) and sennoside. <i>Gastroenterol Jpn</i>, 1992;27:728-733.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/senna-drug-information/abstract-text/1468604/pubmed" id="1468604" target="_blank">1468604</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-10891521">
<a name="10891521"></a>Ito S. Drug therapy for breast-feeding women. <i>N Engl J Med</i>. 2000;343(2):118-126.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/senna-drug-information/abstract-text/10891521/pubmed" id="10891521" target="_blank">10891521</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25223578">
<a name="25223578"></a>Johnson DA, Barkun AN, Cohen LB, et al. Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the US multi-society task force on colorectal cancer. <i>Am J Gastroenterol</i>, 2014;109(10):1528-1545.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/senna-drug-information/abstract-text/25223578/pubmed" id="25223578" target="_blank">25223578</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Perdiem.1">
<a name="Perdiem.1"></a>Perdiem (sennosides) [prescribing information]. Warren, NJ: GSK Consumer Healthcare; received May 2020.</div>
</li>
<li>
<div class="reference">
                  Senexon syrup (sennosides) [prescribing information]. Livonia, MI: Rugby; February 2013.</div>
</li>
<li>
<div class="reference">
                  Senna Liquid (sennosides) [prescribing information]. Livonia, MI: Rugby Laboratories; October 2019.</div>
</li>
<li>
<div class="reference">
                  Senna Syrup (sennosides) [prescribing information]. Southlake, TX: Method Pharmaceuticals, LLC; January 2021.</div>
</li>
<li>
<div class="reference">
                  Senna Syrup (senna leaf extract) [prescribing information]. Greenville, SC: Pharmaceutical Associates, Inc; June 2017.</div>
</li>
<li>
<div class="reference">
                  Senokot tablet (senna) [prescribing information]. Stamford, CT: Purdue Products L.P.; February 2013.</div>
</li>
<li>
<div class="reference">
                  Senokot tablets (senna concentrate) [prescribing information]. Stamford, CT: Purdue; 2011</div>
</li>
<li>
<div class="reference">
                  Senokot tablets (senna concentrate) [prescribing information]. Stamford, CT: Purdue; 2020.</div>
</li>
<li>
<div class="reference">
                  Senokot XTRA tablets (senna concentrate) [prescribing information]. Stamford, CT: Purdue; 2016.</div>
</li>
<li>
<div class="reference">
                  Senokot XTRA tablets (senna concentrate) [prescribing information]. Stamford, CT: Purdue; December 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-6996138">
<a name="6996138"></a>Shelton MG. Standardized senna in the management of constipation in the puerperium: a clinical trial. <i>S Afr Med J</i>. 1980;57(3):78-80.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/senna-drug-information/abstract-text/6996138/pubmed" id="6996138" target="_blank">6996138</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24345831">
<a name="24345831"></a>Tabbers MM, DiLorenzo C, Berger MY, et al; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition; North American Society for Pediatric Gastroenterology. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. <i>J Pediatr Gastroenterol Nutr</i>. 2014;58(2):258-274. doi:10.1097/MPG.0000000000000266<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/senna-drug-information/abstract-text/24345831/pubmed" id="24345831" target="_blank">24345831</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29429768">
<a name="29429768"></a>Vilanova-Sanchez A, Gasior AC, Toocheck N, et al. Are Senna based laxatives safe when used as long term treatment for constipation in children? <i>J Pediatr Surg</i>. 2018;53(4):722-727. doi:10.1016/j.jpedsurg.2018.01.002<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/senna-drug-information/abstract-text/29429768/pubmed" id="29429768" target="_blank">29429768</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-4511106">
<a name="4511106"></a>Werthmann MW Jr, Krees SV. Quantitative excretion of Senokot in human breast milk. <i>Med Ann Dist Columbia</i>. 1973;42(1):4-5.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/senna-drug-information/abstract-text/4511106/pubmed" id="4511106" target="_blank">4511106</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-WHO.1">
<a name="WHO.1"></a>World Health Organization (WHO). Breastfeeding and maternal medication, recommendations for drugs in the eleventh WHO model list of essential drugs. 2002. Available at http://www.who.int/maternal_child_adolescent/documents/55732/en/
                  </div>
</li></ol></div><div id="topicVersionRevision">Topic 10260 Version 510.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
